Janux stock plunges after hours following mCRPC trial data
After-hours movers:
MongoDB (MDB) rose 16% after reporting quarterly results that easily beat analyst estimates. Total revenue was $628.3 million for the third quarter of fiscal 2026, an increase of 19% year-over-year.
Instacart (CART) fell 5% following reports that Amazon (AMZN) is developing a new ultrafast grocery delivery service.
Iris Energy (IREN) fell 5% after it announced plans to offer $2 billion in convertible senior notes through a private placement to qualified institutional buyers.
Credo Technology Group (CRDO) rose 14% after it reported Q2 EPS of $0.67, $0.18 better than the analyst estimate of $0.49. Revenue for the quarter came in at $268 million versus the consensus estimate of $234.67 million.
Janux Therapeutics (JANX) fell 30% after it announced interim data from its Phase 1 clinical trial of JANX007, an experimental treatment for metastatic castration-resistant prostate cancer.
